Skip to contentV
Vsee Health, Inc.
V
VSEEWVsee Health, Inc. Q3 2024 · 10-Q
Revenue$3.35M$3.35M+134.1% vs Q3 2023 Net Income-$53.92M-$53.92MN/M vs Q3 2023 EPS Diluted-$3.58-$3.58N/M vs Q3 2023 Gross Profit$2,784,703+191.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vsee Health, Inc. · CIK 1864531 · Engraved from SEC EDGAR
Operating Cash Flowderived-$221,034N/M Free Cash Flowderived-$226,028N/M Margins · derivedGross margin83.0%+16.4 pt vs Q3 2023
Operating margin-1737.8%−1713.2 pt vs Q3 2023
Net margin-1607.5%−1594.3 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end